Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yanli Xiong
Army Medical University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
51
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Anlotinib Plus Camrelizumab and Chemotherapy as First-Line Treatment in Patients with Advanced Esophageal Squamous Cell Carcinoma. The TCAC-ESCC-01 Phase 2 Nonrandomized Clinical Trial
Number of pages: 41
Posted: 10 Nov 2023
Mingfang Xu
,
Yu Pu
,
Yuzhu Jiang
,
Yingda Liu
,
Kunkun Li
,
Wei Guan
,
Yan Feng
,
Nan Dai
, Yanli Xiong,
Xiao Yang
,
Dong Wang
,
Xiaodong Zhao
and
Mengxia Li
Army Medical University, Daping Hospital - Cancer Department, Army Medical University, Army Medical University, Army Medical University, Chongqing Medical University, Army Medical University, Army Medical University, Army Medical University, Army Medical University, Army Medical University, Army Medical University, Army Medical University and Army Medical University
Downloads
51
(1,063,489)
View PDF
Download
Abstract:
esophageal squamous cell carcinoma, ESCC, ICIs, PD-1, anlotinib
Feedback
